RIFAMPICIN RESISTANT TUBERCULOSIS

Clinical trials for RIFAMPICIN RESISTANT TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new RIFAMPICIN RESISTANT TUBERCULOSIS trials appear

Sign up with your email to follow new studies for RIFAMPICIN RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New hope for fighting tough tuberculosis strains

Disease control Recruiting now

This study is testing a new drug, JDB0131, combined with other medicines to treat tuberculosis that is resistant to standard antibiotics. It will involve 60 patients with this hard-to-treat form of TB to see if the new combination is effective and safe over 8 weeks. The main goal…

Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS

Phase: PHASE2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

RIFAMPICIN RESISTANT TUBERCULOSIS

Get alerted when new RIFAMPICIN RESISTANT TUBERCULOSIS trials appear

New hope for fighting tough tuberculosis strains